Detalhe da pesquisa
1.
Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V.
Haematologica
; 98(9): 1450-7, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23539538
2.
Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA.
Exp Hematol
; 42(4): 282-293.e4, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24407160